Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?

Authors

Jimmy T Efird
Charulata Jindal
Timothy Fitzgerald, Maine Medical Center
Tithi Biswas

Document Type

Article

Publication Date

1-1-2018

Institution/Department

Surgery; Oncology

Journal Title

Transl Gastroenterol Hepatol

MeSH Headings

Leucovorin, onartuzumab, Oxaliplatin, Antibodies, Monoclonal, Fluorouracil, Adenocarcinoma, Epithelial-Mesenchymal Transition, ErbB Receptors

ISSN

2415-1289

First Page

58

Last Page

58

Recommended Citation

Efird, Jimmy T; Jindal, Charulata; Fitzgerald, Timothy; and Biswas, Tithi, "Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?" (2018). MaineHealth Maine Medical Center. 1444.
https://knowledgeconnection.mainehealth.org/mmc/1444